ASCO publishes a suite of peer-reviewed journals with content focused on

  • clinical oncology research;
  • issues and insights affecting oncology practice;
  • cancer care, research, and care delivery issues unique to countries and settings with limited health care resources;
  • biomedical informatics methods and processes applied to cancer-related data, information, and images; and
  • the science and practice of precision oncology.

ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author. Credentialed media can access published articles on the ASCO Publications site using their login information.

ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles.

Publishing April 15, 2024, 4:00 PM ET:

Utilization and Outcomes of Multigene Panel Testing in Patients With Pancreatic Ductal Adenocarcinoma (Original Report)
Derk Klatte, et al
Request article

Genomic Considerations in the Treatment of Thyroid Carcinoma (Editorial)
Crystal Hattum, et al
Request article

Organizational Breast Cancer Data Mart: A Solution for Assessing Outcomes of Imaging and Treatment (Original Report)
Margarita Zuley, et al
Request article

Publishing April 12, 2024, 4:00 PM ET:

Design and Implementation of an Opt-Out, End-to-End, Preemptive DPYD Testing Program for Patients Planned for a Systemic Fluoropyrimidine (Original Report)
Joseph O. Jacobson, et al
Request article

Machine Learning–Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma (Original Report)
Rasmus Rask Kragh Jørgensen, et al
Request article

Publishing April 11, 2024, 4:00 PM ET:

Impact of Propofol Exposure on Neurocognitive Outcomes in Children With High-Risk B ALL: A Children’s Oncology Group Study (Original Report)
Sarah Alexander, et al
Request article

Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease (Original Report)
Jonas Abrahamsson, et al
Request article

Shining a Light: Unveiling Cardiac Risks Using Positron Emission Tomography Imaging in Lung Cancer Radiotherapy (Editorial)
Tobias Finazzi, et al
Request article

Envisioning Academic Global Oncologists: Proposed Competencies for Global Oncology Training from the American Society of Clinical Oncology (ASCO) (Special Article)
Maria Bourlon, et al
Request article

Financial Hardship Among Women With Breast Cancer in Addis Ababa Ethiopia: A Comparative Cross-Sectional Study (Original Report)
Alem Gebremariam, et al
Request article

Real-World Challenges of Managing Diffuse Large B-Cell Lymphoma in a Developing Country (Original Report)
Raheel Iftikhar, et al
Request article

Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in HR+/HER2- Advanced Breast Cancer: The BrasiLEEira Study (Original Report)
Anna M. Buehler, et al
Request article

Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1 (Original Report)
Jun Gong, et al
Request article

NF1-Driven Rhabdomyosarcoma Phenotypes: A Comparative Clinical and Molecular Study of NF1-Mutant Rhabdomyosarcoma and NF1-Associated Malignant Triton Tumor (Original Report)
Cristina Antonescu, et al
Request article

Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2 (Original Report)
Jun Gong, et al
Request article

Published April 8, 2024, 4:00 PM ET:

Therapy for Stage IV Non–Small Cell Lung Cancer With and Without Driver Alterations: ASCO Living Guideline Clinical Insights (Special Article)
ASCO Guidelines, et al
Request article

Association Between Body Composition and Survival in Patients With Gastroesophageal Adenocarcinoma: An Automated Deep Learning Approach (Original Report)
Matthias Jung, et al
Request article

Published April 5, 2024, 4:00 PM ET:

Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRASG12C-Mutated Non–Small Cell Lung Cancer: A Case Series and Literature Review (Original Report)
Hatim Husain, et al
Request article

Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations (Original Report)
Andrew Armstrong, et al
Request article

MIR145 Core Promoter Methylation in Pretreatment Cell-Free DNA: A Liquid Biopsy Tool for Muscle-Invasive Bladder Cancer Treatment Outcome (Original Report)
Margaritis Avgeris, et al
Request article

Published April 4, 2024, 4:00 PM ET:

Prevalence and Cancer-Specific Patterns of Functional Disability Among US Cancer Survivors, 2017-2022 (Original Report)
Chao Cao, et al
Request article

A Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy (IMRT) For Locally Advanced Vulvar Squamous Cell Carcinoma – NRG Oncology/GOG Study 279 (Original Report)
Neil Horowitz, et al
Request article

Service Evaluation of MyChristie-MyHealth, an Electronic Patient-Reported Outcome Measure Integrated Into Clinical Cancer Care (Original Report)
Lee Shipman, et al
Request article

Expanding Myeloma Training and Care in Western Kenya through the ECHO Model: The Pilot Phase (Special Article)
Mercy Atieno Oduor, et al
Request article

Pan-Canadian Survey of Radiation Oncology Professional Involvement in Global Oncology Initiatives in Low- and Middle-Income Countries (Original Report)
Matthew Beckett, et al
Request article

Lung Cancer Clinical Trials in Latin America in the Era of Cooperative Groups: A 20-Year Analysis (Original Report)
Thomas Knapp, et al
Request article

Published April 3, 2024, 4:00 PM ET:

Validating Risk Prediction Models for Multiple Primaries and Competing Cancer Uutcomes in Families With Li-Fraumeni Syndrome Using Clinically Ascertained Data at a Single Institute (Original Report)
Wenyi Wang, et al
Request article

Recently published Journal articles are featured on the homepage of each ASCO Journal website. Credentialed media can directly access these articles using their Media HQ login information on the Journal website. You will only need to log in once to access content for all ASCO Journals:

To apply for ASCO media credentials or renew your credentials, visit ASCO’s Media Headquarters and click “Create Account” or log in with your existing account information. To request your username or reset your password, click “Need Help. After submitting the required documentation, you will receive an email notification once your media credentials are approved. Your access to Journal articles will be activated within one week of approval. As you await access, once you have received notification of approved media credentials, submit your requested articles to Journal Request to receive them by email. 

The embargo date and time of a journal article coincide with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year and may affect broader ASCO media privileges as well. Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.